$VRTX

$514.24 -$3.26 (0.63%) Live

$VRTX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$VRTX Management Team

Ms. Joy Liu

Corporate Secretary

Age 46

Compensation -

Sex Female

Dr. Jeffrey Leiden

Executive Chairman of the Board

Age 69

Compensation $6.595M USD

Sex Male

Dr. Reshma Kewalramani

President

Chief Executive Officer

Director

Age 52

Compensation $21.54M USD

Sex Female

Mr. Charles Wagner

Chief Financial Officer

Chief Operating Officer

Executive Vice President

Age 57

Compensation $7.999M USD

Sex Male

Dr. David Altshuler

Executive Vice President

Chief Scientific Officer

Age 60

Compensation $7.637M USD

Sex Male

Dr. Carmen Bozic

Executive Vice President - Global Medicines Development and Medical Affairs

Chief Medical Officer

Age 62

Compensation -

Sex Female

Ms. Susie Lisa

Senior Vice President

Investor Relations

Age -

Compensation -

Sex Female

Dr. E. Morrow Atkinson

Executive Vice President

Chief Technical Operations Officer

Head of Biopharmaceutical Science and Manufacturing Operations

Age 59

Compensation -

Sex Male

Mr. Jonathan Biller

Executive Vice President

Chief Legal Officer

Age 61

Compensation -

Sex Male

Mr. Duncan Mckechnie

Executive Vice President

Chief Commercial Officer

Age 56

Compensation -

Sex Male

Mr. Amit Sachdev

Executive Vice President

Chief Patient and External Affairs Officer

Age 57

Compensation $6.197M USD

Sex Male

Dr. Ourania Tatsis

Executive Vice President

Chief Regulatory and Quality Officer

Age 55

Compensation $7.334M USD

Sex Female

Ms. Kristen Ambrose

Senior Vice President

Chief Accounting Officer

Age 48

Compensation -

Sex Female

Name / Title	Age	Compensation	Sex
Ms. Joy Liu Corporate Secretary	46	-	Female
Dr. Jeffrey Leiden Executive Chairman of the Board	69	$6.595M USD	Male
Dr. Reshma Kewalramani President Chief Executive Officer Director	52	$21.54M USD	Female
Mr. Charles Wagner Chief Financial Officer Chief Operating Officer Executive Vice President	57	$7.999M USD	Male
Dr. David Altshuler Executive Vice President Chief Scientific Officer	60	$7.637M USD	Male
Dr. Carmen Bozic Executive Vice President - Global Medicines Development and Medical Affairs Chief Medical Officer	62	-	Female
Ms. Susie Lisa Senior Vice President Investor Relations	-	-	Female
Dr. E. Morrow Atkinson Executive Vice President Chief Technical Operations Officer Head of Biopharmaceutical Science and Manufacturing Operations	59	-	Male
Mr. Jonathan Biller Executive Vice President Chief Legal Officer	61	-	Male
Mr. Duncan Mckechnie Executive Vice President Chief Commercial Officer	56	-	Male
Mr. Amit Sachdev Executive Vice President Chief Patient and External Affairs Officer	57	$6.197M USD	Male
Dr. Ourania Tatsis Executive Vice President Chief Regulatory and Quality Officer	55	$7.334M USD	Female
Ms. Kristen Ambrose Senior Vice President Chief Accounting Officer	48	-	Female

Board of Directors

From the proxy statement filed Apr 2, 2026

Directors

serving now

Independent

9 of 9

stated in the proxy; 2 not stated

Average tenure

8.7 years

from year joined

CEO also chairs the board

Jeffrey Leiden

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Sangeeta Bhatia	57	2015 11 years	Independent	Science and Technology Committee · Chair Corporate Governance and Nominating Committee	None stated	$560,364
Lloyd Carney	64	2019 7 years	Independent	Corporate Governance and Nominating Committee · Chair Audit and Finance Committee	Visa Inc., Grid Dynamics Holdings Inc.	$565,364
Alan Garber	70	2017 9 years	Independent	Corporate Governance and Nominating Committee Science and Technology Committee	None stated	$545,247
Reshma Kewalramani CEO	53	2020 6 years	Not stated	None stated	None stated	Paid as CEO
Michel Lagarde	52	2023 3 years	Independent	Audit and Finance Committee	None stated	$540,130
Jeffrey Leiden Board chair	70	2009 17 years	Not stated	None stated	None stated	Not stated
Diana McKenzie	61	2020 6 years	Independent	Audit and Finance Committee Management Development and Compensation Committee	MetLife Inc., agilon health, inc.	$552,864
Bruce Sachs Lead independent director	66	1998 28 years	Independent	Management Development and Compensation Committee · Chair Corporate Governance and Nominating Committee	None stated	$615,130
Jennifer Schneider	51	2024 2 years	Independent	Management Development and Compensation Committee	None stated	$537,864
Nancy Thornberry	69	2023 3 years	Independent	Science and Technology Committee	Denali Therapeutics, Schrödinger Inc.	$528,247
Suketu Upadhyay	57	2022 4 years	Independent	Audit and Finance Committee · Chair Management Development and Compensation Committee	None stated	$565,864

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

1 disclosed in the proxy filed Apr 2, 2026

daughter of our Chief Operating and Financial Officer

Approximately $155,000 in total compensation

2025

Daughter employed by the Company in a non-executive position; received total compensation and participated in employee benefit plans on the same basis as similarly situated employees.

With the Company Open in proxy

Comments

Company Executives

$VRTX Management Team

Ms. Joy Liu

Dr. Jeffrey Leiden

Dr. Reshma Kewalramani

Mr. Charles Wagner

Dr. David Altshuler

Dr. Carmen Bozic

Ms. Susie Lisa

Dr. E. Morrow Atkinson

Mr. Jonathan Biller

Mr. Duncan Mckechnie

Mr. Amit Sachdev

Dr. Ourania Tatsis

Ms. Kristen Ambrose

Board of Directors

Related-party transactions